Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron M Allen

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Cancer|February 21, 2008
Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experienceAaron M Allen, Steven J Mentzer, Beow Y Yeap, et al.
Journal of Cardiothoracic Surgery|January 11, 2019
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexityDan Aravot, Yaron D Barac, Efrat Krutzwald-Josefson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Clinical utility of 4D FDG-PET/CT scans in radiation treatment planningMichalis Aristophanous, Ross I Berbeco, Joseph H Killoran, et al.
The Israel Medical Association Journal : IMAJ|January 14, 2020
Stereotactic Radiosurgery for Brain Metastases in Small Cell Lung Cancer: The Davidoff Cancer Center ExperienceElizabeth Dudnik, Aaron M Allen, Natalia Michaeli, et al.
Oncology|July 11, 2021
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerOded Jacobi, Yosef Landman, Daniel Reinhorn, et al.
International Journal of Radiation Oncology, Biology, Physics|August 7, 2007
Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomyAaron M Allen, Robert Den, Julia S Wong, et al.
Frontiers in Oncology|March 29, 2021
BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase InhibitorsElizabeth Dudnik, Jair Bar, Assaf Moore, et al.
Asia-Pacific Journal of Clinical Oncology|August 8, 2020
Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancerOded Icht, Liran Domachevsky, David Groshar, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabineAaron M Allen, Mark M Zalupski, John M Robertson, et al.
Cancer Journal (Sudbury, Mass.)|November 5, 2005
Body mass index predicts the incidence of radiation pneumonitis in breast cancer patientsAaron M Allen, Robert G Prosnitz, Randall K Ten Haken, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Cancer|February 21, 2008
Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experienceAaron M Allen, Steven J Mentzer, Beow Y Yeap, et al.
Journal of Cardiothoracic Surgery|January 11, 2019
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexityDan Aravot, Yaron D Barac, Efrat Krutzwald-Josefson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Clinical utility of 4D FDG-PET/CT scans in radiation treatment planningMichalis Aristophanous, Ross I Berbeco, Joseph H Killoran, et al.
The Israel Medical Association Journal : IMAJ|January 14, 2020
Stereotactic Radiosurgery for Brain Metastases in Small Cell Lung Cancer: The Davidoff Cancer Center ExperienceElizabeth Dudnik, Aaron M Allen, Natalia Michaeli, et al.
Oncology|July 11, 2021
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerOded Jacobi, Yosef Landman, Daniel Reinhorn, et al.
International Journal of Radiation Oncology, Biology, Physics|August 7, 2007
Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomyAaron M Allen, Robert Den, Julia S Wong, et al.
Frontiers in Oncology|March 29, 2021
BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase InhibitorsElizabeth Dudnik, Jair Bar, Assaf Moore, et al.
Asia-Pacific Journal of Clinical Oncology|August 8, 2020
Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancerOded Icht, Liran Domachevsky, David Groshar, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabineAaron M Allen, Mark M Zalupski, John M Robertson, et al.
Cancer Journal (Sudbury, Mass.)|November 5, 2005
Body mass index predicts the incidence of radiation pneumonitis in breast cancer patientsAaron M Allen, Robert G Prosnitz, Randall K Ten Haken, et al.
Pageof 8